Detalhe da pesquisa
1.
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH.
Hepatology
; 77(1): 20-32, 2023 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35686937
2.
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.
Gut
; 72(3): 581-589, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36750244
3.
Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: prevention by fenofibrate.
J Lipid Res
; 64(3): 100339, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36737040
4.
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores.
J Hepatol
; 78(2): 247-259, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36375686
5.
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.
Clin Gastroenterol Hepatol
; 21(1): 143-152.e3, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34999207
6.
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD.
Hepatology
; 76(6): 1811-1824, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35561146
7.
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.
Hepatology
; 75(5): 1235-1246, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34662449
8.
Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients.
J Lipid Res
; 63(9): 100250, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35835205
9.
Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial.
J Hepatol
; 77(3): 607-618, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35439567
10.
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Hepatology
; 73(2): 625-643, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33169409
11.
Automated CNN-Based Analysis Versus Manual Analysis for MR Elastography in Nonalcoholic Fatty Liver Disease: Intermethod Agreement and Fibrosis Stage Discriminative Performance.
AJR Am J Roentgenol
; 219(2): 224-232, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35107306
12.
Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH.
Cell Rep Med
; 4(4): 101016, 2023 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37075704
13.
Synovial tissue-infiltrating natural killer cells in osteoarthritis and periprosthetic inflammation.
Arthritis Rheum
; 62(12): 3799-805, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20848566
14.
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.
Hepatol Commun
; 5(7): 1201-1211, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34278169